SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiopharma Cred. Regulatory News (BPCR)

Share Price Information for Biopharma Cred. (BPCR)

Share Price is delayed by 15 minutes
Get Live Data
0.944    0.00 (0.00%)
Bid:
0.944
Ask:
0.946
Spread: 0.002 (0.212%)
Market Cap: $1.06b
BPCR Live PriceLast checked at - London Stock Exchange

Intraday Biopharma Cred. Share Chart

Director/PDMR Shareholding

12 May 2025 15:36

RNS Number : 3214I
BioPharma Credit PLC
12 May 2025
 

BIOPHARMA CREDIT PLC

 

Notification of Transactions by

Persons Discharging Managerial Responsibilities and

Persons Closely Associated with them

 

1.

Details of person discharging managerial responsibilities/person closely associated with them

a)

Name

Anita Hyman

2.

Reason for the notification

a)

Position / status

Person Closely Associated with Harry Hyman (Director of BioPharma Credit PLC)

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

BioPharma Credit PLC

b)

LEI

213800AV55PYXAS7SY24

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

 

Identification Code

Ordinary Shares of $0.01 each

 

 

GB00BDGKMY29

b)

Nature of the transaction

Purchase of Shares (acquired as part of dividend reinvestment)

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.657382

75

d)

Aggregated information

- Aggregated volume

 

- Price

 

 

N/A

 

 

e)

Date of the transaction

07.05.2025

f)

Place of the transaction

London Stock Exchange (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBSGDUUXBDGUD
Date   Source Headline
31st Oct 20233:30 pmRNSDirector Declaration
24th Oct 20237:00 amRNSUPDATE ON INVESTMENT
20th Oct 20234:00 pmRNSNet Asset Value(s) and Monthly Factsheet
12th Oct 20237:00 amRNSUPDATE ON INVESTMENT
2nd Oct 20231:32 pmRNSDirector/PDMR Shareholding
27th Sep 20237:00 amRNSHalf-year Report
26th Sep 202311:20 amRNSUPDATE ON INVESTMENT
22nd Sep 20234:00 pmRNSNet Asset Value(s) and Monthly Factsheet
19th Sep 20237:00 amRNSUpdate on Investment
31st Aug 20237:00 amRNSNotice of Half Year Results
29th Aug 202311:25 amRNSUpdate on Investment
23rd Aug 20234:30 pmRNSNet Asset Value(s) and Monthly Factsheet
10th Aug 20237:00 amRNSDividend Declaration
1st Aug 202311:29 amRNSTotal Voting Rights
31st Jul 20237:00 amRNSSTATEMENT RE REATA PHARMACEUTICALS
21st Jul 20234:00 pmRNSNet Asset Value(s)
21st Jul 202311:30 amRNSUPDATE ON INVESTMENT
18th Jul 20237:00 amRNSUPDATE ON INVESTMENT
11th Jul 20236:15 pmRNSTransaction in Own Shares
10th Jul 20236:15 pmRNSTransaction in Own Shares
3rd Jul 20231:34 pmRNSTotal Voting Rights
3rd Jul 20237:00 amRNSUpdate on Investment
30th Jun 20236:15 pmRNSTransaction in Own Shares
29th Jun 20236:15 pmRNSTransaction in Own Shares
26th Jun 20236:15 pmRNSTransaction in Own Shares
22nd Jun 20236:15 pmRNSTransaction in Own Shares
21st Jun 20234:00 pmRNSNet Asset Value(s)
20th Jun 20236:15 pmRNSTransaction in Own Shares
15th Jun 20236:15 pmRNSTransaction in Own Shares
13th Jun 20236:15 pmRNSTransaction in Own Shares
8th Jun 20236:15 pmRNSTransaction in Own Shares
8th Jun 20237:00 amRNSUPDATE ON INVESTMENT
7th Jun 20236:15 pmRNSTransaction in Own Shares
6th Jun 20236:15 pmRNSTransaction in Own Shares
1st Jun 202312:04 pmRNSTotal Voting Rights
31st May 20236:15 pmRNSTransaction in Own Shares
30th May 20233:08 pmRNSResult of AGM
26th May 20236:15 pmRNSTransaction in Own Shares
25th May 20236:15 pmRNSTransaction in Own Shares
24th May 20236:15 pmRNSTransaction in Own Shares
23rd May 20236:15 pmRNSTransaction in Own Shares
23rd May 20234:00 pmRNSNet Asset Value(s)
19th May 20236:15 pmRNSTransaction in Own Shares
19th May 20237:00 amRNSUpdate on Investment
18th May 20236:15 pmRNSTransaction in Own Shares
16th May 20233:40 pmRNSDirector/PDMR Shareholding
11th May 20237:00 amRNSNEW INVESTMENT OF UP TO US$137.5 MILLION
9th May 20236:15 pmRNSTransaction in Own Shares
5th May 20236:15 pmRNSTransaction in Own Shares
2nd May 20236:15 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.